Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Eur Heart J ; 40(23): 1837-1846, 2019 06 14.
Article in English | MEDLINE | ID: mdl-30793735

ABSTRACT

AIMS: This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months. METHODS AND RESULTS: The RM-ALONE is a multicentre prospective trial that randomly assigned 445 patients in two groups, both followed by RM: the home monitoring-only (HMo) based on RM + remote interrogations (RIs) every 6 months and the HM + IO that adds in-office evaluations every 6 months to RM. Four hundred and forty-five patients were enrolled in the study, 294 PMs and 151 ICDs recipients. In the HMo group, 20% of patients experienced ≥1 major adverse cardiac event (MACE) vs. 19.5% in HM + IO group (P = 0.006 for non-inferiority). The proportion of patients with a PM/ICD who experienced ≥1 MACE was 15.2/29.3% in HMo group and 16.1/26.3% in HM + IO group (hazard ratio 0.95/1.15, 95% confidence interval 0.53-1.70/0.62-2.10). There were 789 in-office evaluations (136 in the HMo and 653 in the HM + IO; P < 0.001). There was a 79.2% reduction of in-office evaluations with no significant differences in unscheduled visits between groups: 122 (54.5%) in HMo and 101 (45.3%) in HM + IO; P = 0.15. The time a physician/nurse spent per patient/follow-up was significantly reduced in the HMo group: 4/5 min (0-30)/(1-30) vs. 10/10 min (0-40)/(1-40) in HM + IO (P < 0.0001). CONCLUSION: The RM-ALONE protocol common for ICD and PM surveillance, consisting of RM + RI every 6 months has proven safe and efficient in reducing hospital visits and staff workload.


Subject(s)
Defibrillators, Implantable/adverse effects , Home Care Services , Monitoring, Physiologic/methods , Pacemaker, Artificial/adverse effects , Telemedicine/methods , Adult , Aged , Aged, 80 and over , Cardiovascular Diseases/mortality , Female , Hospitalization/statistics & numerical data , Humans , Male , Middle Aged , Prospective Studies , Workload/statistics & numerical data , Young Adult
2.
J Interv Card Electrophysiol ; 15(3): 171-4, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16955361

ABSTRACT

Patients with orthotopic heart transplantation may have a variety of arrhythmias. There are reports of successful radiofrequency catheter ablation of some of them. Two months after orthotopic cardiac transplantation by bicaval anastomosis, a 49-year-old man developed episodes of tachycardia. The patient developed with dyspnoea and hypotension during typical atrioventricular nodal reentrant tachycardia (AVNRT) revealed by electrocardiogram. During programmed atrial stimulation with progressively increasing prematurity, dual auriculoventricular nodal physiology was observed and AVNRT was induced. This tachycardia was successfully eliminated without complications by radiofrequency catheter ablation of the slow pathway. The patient remained asymptomatic at 4-month follow-up.


Subject(s)
Anastomosis, Surgical/methods , Catheter Ablation/methods , Heart Transplantation , Tachycardia, Atrioventricular Nodal Reentry/prevention & control , Venae Cavae/surgery , Cardiomyopathy, Dilated/complications , Cardiomyopathy, Dilated/surgery , Humans , Male , Middle Aged , Secondary Prevention , Tachycardia, Atrioventricular Nodal Reentry/etiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...